Form 4: Ardent Health Partners Director Acquires Shares Through Restricted Stock Units

Director Suzanne Campion acquired 10,793 shares of Ardent Health Partners common stock through the vesting of restricted stock units.

Summary

• Suzanne Campion, a director at Ardent Health Partners, acquired 10,793 shares of common stock on December 12, 2024.
• The acquisition was through the vesting of restricted stock units.
• These restricted stock units vest in three equal installments annually starting December 12, 2024.
• The vesting is subject to pro-rata vesting if the director's service terminates under certain circumstances related to the company's annual meeting of stockholders.
• Following the transaction, Ms. Campion directly owns 31,068 shares of Ardent Health Partners common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a routine transaction of a director acquiring shares through vesting, which is a normal part of compensation and can indicate confidence in the company.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It reflects the compensation structure for board members.

Comparison to Industry Standards

• The vesting of restricted stock units is a common practice for compensating directors in publicly traded companies.
• The vesting schedule of three equal annual installments is also a standard approach.
• Similar filings are regularly made by directors and officers of comparable companies such as HCA Healthcare and Tenet Healthcare.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it shows a director's increased stake in the company.

Key Dates

Keywords

Ardent Health Partners, Director, Stock Acquisition, Restricted Stock Units, Share Ownership, Form 4, Insider Trading